134 related articles for article (PubMed ID: 21151803)
21. Immunosuppressive treatment of primary cadaveric renal transplant patients receiving kidneys from non-heart beating donors.
Ohshima S; Fujita T; Ono Y; Kinukawa T; Katoh N; Matsuura O
Artif Organs; 1996 Oct; 20(10):1130-6. PubMed ID: 8896734
[TBL] [Abstract][Full Text] [Related]
22. The effect of cyclosporine on early graft function in human renal transplantation.
Flechner SM; Payne WD; Van Buren C; Kerman R; Kahan BD
Transplantation; 1983 Sep; 36(3):268-72. PubMed ID: 6351368
[TBL] [Abstract][Full Text] [Related]
23. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.
Ahsan N; Johnson C; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
Transplantation; 2001 Jul; 72(2):245-50. PubMed ID: 11477347
[TBL] [Abstract][Full Text] [Related]
24. Repeat cadaver kidney transplantation using cyclosporine A immunosuppression.
Anderson PA; Belitsky P; Bitter-Suermann H; Cohen AD; MacDonald AS
J Urol; 1987 Dec; 138(6):1376-8. PubMed ID: 3316714
[TBL] [Abstract][Full Text] [Related]
25. Steroid withdrawal in kidney transplant recipients: is it a safe option?
Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
[TBL] [Abstract][Full Text] [Related]
26. The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors.
Fukuhara N; Ono Y; Hattori R; Nishiyama N; Yamada S; Kamihira O; Kinukawa T; Ohshima S
Clin Transplant; 2005 Apr; 19(2):153-7. PubMed ID: 15740548
[TBL] [Abstract][Full Text] [Related]
27. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years.
Canadian Multicentre Transplant Study Group
N Engl J Med; 1986 May; 314(19):1219-25. PubMed ID: 2871486
[TBL] [Abstract][Full Text] [Related]
28. Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Clin Exp Nephrol; 2007 Jun; 11(2):151-155. PubMed ID: 17593515
[TBL] [Abstract][Full Text] [Related]
29. Retrospective analysis of posttransplantation diabetes mellitus in black renal allograft recipients.
Sumrani NB; Delaney V; Daskalakis P; Davis R; Friedman EA; Hong JH; Sommer BG
Diabetes Care; 1991 Aug; 14(8):760-2. PubMed ID: 1954816
[TBL] [Abstract][Full Text] [Related]
30. [Survival of grafts in the first 100 renal transplants at the Carlos van Buren Hospital].
Poblete H; Toro J; Nicovani V; Cevallos M; Orriols M
Rev Med Chil; 2001 Jul; 129(7):763-72. PubMed ID: 11552445
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporine: five years' experience in cadaveric renal transplantation.
Merion RM; White DJ; Thiru S; Evans DB; Calne RY
N Engl J Med; 1984 Jan; 310(3):148-54. PubMed ID: 6361559
[TBL] [Abstract][Full Text] [Related]
32. Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine.
Lee CM; Markezich AJ; Scandling JD; Dafoe DC; Alfrey EJ
J Surg Res; 1998 May; 76(2):131-6. PubMed ID: 9698512
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
[TBL] [Abstract][Full Text] [Related]
34. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
35. Excellent long-term graft survival in low risk, primary renal allografts treated with prednisolone-avoidance immunosuppression.
Elias TJ; Bannister KM; Clarkson AR; Russ GR; Mathew TH; Barratt LJ; Faull RJ
Clin Transplant; 2000 Apr; 14(2):157-61. PubMed ID: 10770422
[TBL] [Abstract][Full Text] [Related]
36. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
Johnson C; Ahsan N; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; van Veldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
Transplantation; 2000 Mar; 69(5):834-41. PubMed ID: 10755536
[TBL] [Abstract][Full Text] [Related]
37. Significance of delayed graft function in cyclosporine-treated recipients of cadaver kidney transplants.
Barry JM; Shively N; Hubert B; Hefty T; Norman DJ; Bennett WM
Transplantation; 1988 Feb; 45(2):346-8. PubMed ID: 3278427
[TBL] [Abstract][Full Text] [Related]
38. A controlled trial of steroids in cyclosporine-treated renal transplant recipients.
Griffin PJ; Da Costa CA; Salaman JR
Transplantation; 1987 Apr; 43(4):505-8. PubMed ID: 3554643
[TBL] [Abstract][Full Text] [Related]
39. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group.
Sinclair NR
CMAJ; 1992 Sep; 147(5):645-57. PubMed ID: 1521210
[TBL] [Abstract][Full Text] [Related]
40. Does cyclosporine influence the results of cadaver retransplantation?
Flechner SM; Lorber MI; Kerman RH; Van Buren CT; Wideman C; Kahan BD
Hum Immunol; 1985 Nov; 14(3):305-13. PubMed ID: 3902748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
